+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Carmustine"

Glioblastoma Multiforme (GBM) Treatment Global Market Report 2024 - Product Thumbnail Image

Glioblastoma Multiforme (GBM) Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Brain Tumor Drugs Global Market Report 2024 - Product Thumbnail Image

Brain Tumor Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Adult Malignant Glioma Therapeutics Global Market Report 2024 - Product Thumbnail Image

Adult Malignant Glioma Therapeutics Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
From
From
Brain Tumor Drugs Market Forecasts from 2023 to 2028 - Product Thumbnail Image

Brain Tumor Drugs Market Forecasts from 2023 to 2028

  • Report
  • November 2023
  • 140 Pages
  • Global
From
Brain Tumor Therapeutics: Global Markets to 2023 - Product Thumbnail Image

Brain Tumor Therapeutics: Global Markets to 2023

  • Report
  • December 2018
  • 161 Pages
  • Global
From
US Glioma - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

US Glioma - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • April 2023
  • 200 Pages
  • United States
From
From
From
From
From
  • 19 Results (Page 1 of 1)
Loading Indicator

Carmustine is a chemotherapy drug used to treat lymphoma, a type of cancer that affects the lymphatic system. It is a nitrogen mustard alkylating agent, meaning it works by damaging the DNA of cancer cells, preventing them from growing and dividing. It is usually administered intravenously, and is often used in combination with other drugs. Common side effects include nausea, vomiting, hair loss, and fatigue. Carmustine is a widely used drug in the treatment of lymphoma, and is available in both generic and branded forms. It is typically prescribed by oncologists and hematologists, and is available in both oral and injectable forms. It is also used in combination with other drugs, such as rituximab, to treat more advanced forms of lymphoma. The Carmustine market is highly competitive, with a number of companies offering branded and generic versions of the drug. Some of the major players in the market include Bristol-Myers Squibb, Pfizer, Merck, Novartis, and Teva Pharmaceuticals. Show Less Read more